HIF1AN and prostate adenocarcinoma: As shown in Figure 1A, the expression of HIF1AN was downregulated in most cancers such as breast cancer (BRCA), thyroid cancer (THCA), prostate adenocarcinoma (PRAD), and uterine corpus endometrial carcinoma (UCEC).